Evidence-Based Drug Policy Act of 2025 Introduced to Congress – Cannabis Science and Technology
Cannabis Science and Technology reports that Congresswoman Dina Titus and Congresswoman Ilhan Omar recently introduced the Evidence-Based Drug Policy Act of 2025 to Congress, which hopes to change restrictions on cannabis research. The article mentions SSDP as an organization in support of this new legislation.
“Our nation’s drug policies have been shaped by stigma. The American people overwhelmingly support cannabis reform, and yet the federal government continues to tie the hands of its own experts,” said Congresswoman Ilhan Omar (1). “The Evidence-Based Drug Policy Act is about bringing our laws into the 21st century, ensuring that the Office of National Drug Control Policy can do its job guided by facts, not outdated ideology. We need drug policy to follow the science and reflect the reality on the ground in states across the country.”
